Skip to main content
    W

    Werewolf Therapeutics Inc (HOWL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.99
    +0.01 (+1.07%)

    Market Cap: $47.64M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Werewolf Therapeutics Inc (HOWL) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Werewolf Therapeutics (HOWL) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Werewolf Therapeutics reported EPS of -$0.20, above the -$0.22 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    76%(16/21)
    Avg Surprise
    +17.30%
    Streak
    5 Q

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.17
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    HOWL has an expected report date of Mar 22, 2027.

    Earnings History

    Of the 21 quarters below that had an estimate, HOWL beat 16 and missed 5. The widest gap in the table came in the quarter ended Jun 30, 2026, when EPS landed 128.57% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.20-$0.22-$0.22 - -$0.22+9.09%BeatN/A11 up, 0 downNov 13, 2026N/A
    Jun 30, 2026$0.08-$0.28N/A+128.57%BeatN/A11 up, 0 downJul 31, 2026$21.00M
    Mar 31, 2026-$0.28-$0.30-$0.32 - -$0.27+5.08%BeatN/A21 up, 0 downMay 7, 2026N/A
    Dec 31, 2025-$0.17-$0.35-$0.37 - -$0.27+51.43%BeatN/A31 up, 0 downMar 27, 2026N/A
    Sep 30, 2025-$0.36-$0.38-$0.41 - -$0.36+5.26%BeatN/A42 up, 0 downNov 4, 2025N/A
    Jun 30, 2025-$0.40-$0.37-$0.39 - -$0.36-8.11%MissN/A32 up, 0 downAug 14, 2025N/A
    Mar 31, 2025-$0.40-$0.43-$0.45 - -$0.42+6.98%BeatN/A30 up, 1 downMay 8, 2025N/A
    Dec 31, 2024-$0.46-$0.42N/A-9.52%MissN/A33 up, 0 downMar 11, 2025N/A
    Sep 30, 2024-$0.38-$0.39-$0.45 - -$0.36+2.56%BeatN/A60 up, 0 downNov 7, 2024N/A
    Jun 30, 2024-$0.38-$0.39-$0.43 - -$0.29+2.56%BeatN/A50 up, 0 downAug 8, 2024$1.14M
    Mar 31, 2024-$0.39-$0.34-$0.41 - -$0.28-14.71%MissN/A50 up, 0 downMay 3, 2024$742000
    Dec 31, 2023-$0.33-$0.43-$0.53 - -$0.29+23.26%BeatN/A50 up, 0 downMar 7, 2024$1.50M
    Sep 30, 2023-$0.23-$0.34-$0.45 - -$0.27+32.35%BeatN/A50 up, 0 downNov 14, 2023$5.90M
    Jun 30, 2023-$0.14-$0.40-$0.48 - -$0.34+65.00%BeatN/A50 up, 0 downAug 10, 2023$8.08M
    Mar 31, 2023-$0.34-$0.46-$0.59 - -$0.43+26.09%BeatN/A40 up, 0 downMay 11, 2023$4.46M
    Dec 31, 2022-$0.39-$0.55-$0.76 - -$0.38+29.09%BeatN/A50 up, 0 downMar 23, 2023$7.28M
    Sep 30, 2022-$0.40-$0.56-$0.81 - -$0.19+28.57%BeatN/A41 up, 0 downNov 10, 2022$4.97M
    Jun 30, 2022-$0.53-$0.60-$0.62 - -$0.07+11.67%BeatN/A40 up, 0 downAug 11, 2022$4.15M
    Mar 31, 2022-$0.56-$0.58-$0.70 - -$0.45+3.45%BeatN/A40 up, 0 downMay 10, 2022N/A
    Dec 31, 2021-$0.66-$0.53-$0.56 - -$0.50-24.53%MissN/A4N/AMar 24, 2022N/A
    Sep 30, 2021-$0.51-$0.46-$0.54 - -$0.36-10.87%MissN/A4N/ANov 10, 2021N/A
    Jun 30, 2021-$3.82-$0.28-$0.55 - -$0.27N/AN/AN/A3N/AAug 12, 2021N/A
    Mar 31, 2021-$83.36-$0.46N/AN/AN/AN/AN/AN/AApr 30, 2021N/A
    Last 23 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.33, after -$1.61 the year before. It was -$88.35 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.33N/A
    Dec 31, 2024-$1.61N/A
    Dec 31, 2023-$1.04N/A
    Dec 31, 2022-$1.88N/A
    Dec 31, 2021-$88.35N/A

    Frequently Asked Questions About HOWL

    When is Werewolf Therapeutics's next earnings date?

    Werewolf Therapeutics's next earnings report is expected for Mar 22, 2027.

    Did HOWL beat earnings estimates last quarter?

    Yes. Werewolf Therapeutics reported EPS of -$0.20 for the quarter ended Sep 30, 2026, above the -$0.22 estimate, a 9.09% surprise.

    What EPS do analysts expect from HOWL next quarter?

    The consensus EPS estimate for Werewolf Therapeutics for the quarter ending Dec 31, 2026 is -$0.17 from 3 analysts.

    How often does HOWL beat earnings estimates?

    Werewolf Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +23.60%.